Nutritional management during chemotherapy and chemoradiotherapy for advanced esophageal cancer
- PMID: 40155587
- PMCID: PMC12167285
- DOI: 10.1007/s10388-025-01117-8
Nutritional management during chemotherapy and chemoradiotherapy for advanced esophageal cancer
Abstract
Advanced esophageal cancer is treated by chemotherapy, radiation therapy, chemoradiotherapy, and immunotherapy. However, the stenosis caused by the tumor and cancer-related chronic inflammation leads to inadequate food intake, weight loss, and nutrition problems. Given that poor pre-treatment nutritional status increases the risks of treatment-related adverse events and a poor prognosis, the nutrition guidelines recommend a pre-treatment nutritional assessment. When malnutrition is present, nutritional interventions, such as dietary guidance and enteral nutrition supplements, provided by the medical team may reduce treatment-related adverse events. However, whether nutritional intervention improves the prognosis is a topic for future research, including randomized controlled trials. This review discusses the literature on nutritional management in patients undergoing chemotherapy and chemoradiotherapy for advanced esophageal cancer.
Keywords: Advanced esophageal cancer; Chemoradiation; Chemotherapy; Nutritional assessment; Nutritional intervention.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: Ethical approval was obtained from the institutional review and ethics board. Conflict of interest: Y. Ki. has received grants and personal fees from Daiichi Sankyo Co. Ltd., none of which are related to the present article. The remaining authors declare that there are no conflicts of interest.
Figures
References
-
- Muscaritoli M, Arends J, Bachmann P, et al. ESPEN practical guideline: clinical Nutrition in cancer. Clin Nutr. 2021;40:2898–913. - PubMed
-
- Japanese Society for Clinical Nutrition & Metabolism. Textbook of Japanese Society for Clinical Nutrition and Metabolism. Nankodo; 2021. (in Japanese)
-
- Huhmann MB, Cunningham RS. Importance of nutritional screening in treatment of cancer-related weight loss. Lancet Oncol. 2005;6:334–43. - PubMed
-
- Hagi T, Makino T, Yamasaki M, et al. Dysphagia score as a predictor of adverse events due to triplet chemotherapy and oncological outcomes in 434 consecutive patients with esophageal cancer. Ann Surg Oncol. 2019;26:4754–64. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical